Academia Employers Health System Payers Providers

Center on Health Equity and Access Clinical Health Care Cost Health Care Delivery Insurance Policy Technology Value-Based Care

All Coverage Event Coverage Interviews News

AJMC Journals Anniversary Author Forms Authors Nominate a Rising Leader Submit a Manuscript

Stanton R. Mehr

home / authors / stanton-r-mehr

Articles

The Intestinal Bug Hypothesis in Crohn's Disease Gets a Reboot

October 21st 2014

Read More

The Economic Costs of Crohn's Disease

October 21st 2014

Read More

Exploring the Intersection of Chronic Disease, Adherence, and Life Expectancy

October 14th 2014

Read More

Recurrence of Breast Cancer Years After the Initial Tumor

September 19th 2014

Read More

Upending of Conventional Combination Therapy in Type 2 Diabetes Mellitus

September 19th 2014

Read More

Breast Cancer Survivorship Programs: More Than a Treatment

September 19th 2014

Read More

Robotic-Assisted Surgery: A Question of Value

August 25th 2014

Read More

Can Gastric Bypass Surgery Be a Cure for Diabetes Mellitus?

Read More

Inhaled Insulin's Long Journey to Commercialization

Read More

A Patient's Opinion of Unmet Need

Read More

The How and Why of Stress, Diabetes, and the Brain

A Visit With Mark Feinglos, MD, and Richard Surwit, PhD

Read More

Increasing Access to HIV Care May Help Improve Outcomes

April 22nd 2014

Read More

Targeted Programmed Cell Death in Lung Cancer Treatment

March 19th 2014

Read More

The Link Between a Common Type of Bariatric Surgery and Increased Alcohol Use

March 17th 2014

Read More

The Continuing Evolution of Employer-Based Intervention in Diabetes Disease Management

March 17th 2014

Read More

What Is the Place of New SGLT-2 Inhibitors in Therapy and on the Formulary?

March 13th 2014

Read More

Is Medicare Ready for Oncology Clinical Pathways?

February 11th 2014

Read More

Attacking Complications to Kidney Problems in Diabetes: Atrial Fibrillation and Resistant Hypertension

January 21st 2014

Read More

Nonincretin Drugs in Later-Stage Development

January 21st 2014

Read More

New Approaches to Medicaid Expansion: Hybrid Plans Offer Alternatives for Covering More People

October 22nd 2013

Read More

The Next Frontier for the Artificial Pancreas: Payer Coverage

September 27th 2013

Read More

Sequester Forcing Chemo Treatments into Hospitals Costing Taxpayers More in the End

August 20th 2013

Read More

BMI and Beyond: Identifing Obesity in Patients at Risk for Diabetes and Heart Disease

Read More

Innovations on the Horizon for the Treatment of Type 2 Diabetes An Interview With Javier Morales, MD

Read More

Searching for Clinical and Economic Value in Pancreatic Cancer

Read More

Chemoprevention in Prostate Cancer: Identifying Patients at Greatest Risk May Provide Greatest Value

Read More

Applying Accountable Care to Oncology: Developing an Oncology ACO

The cost-saving potential of specialty or disease-specific ACOs can be huge...but it is unclear whether these specialty services are more efficiently provided through their own ACO or as ancillary to the burgeoning primary care ACO marketplace.

Read More

Value-Based Contracting for Pharmaceuticals: Getting Ready for Prime Time?

Read More

Is There a Business Case for Diabetes Disease Management?

April 11th 2013

Read More

The Complexity of Covering Off-Label Use for a Multitude of Oncology Regimens

December 7th 2012

Read More

Editorial Staff

Editorial Boards

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences
AJMC®
All rights reserved.